Back

IDEXX Laboratories Inc

Ticker: IDXX ISIN: US45168D1046
Add to portfolio Portfolio analysis in 2min
Stock Large-cap High beta Trading above 200-day average Near 52-week high
Market cap
$34.63B
P/E
40.82
Forward P/E
37.04
Profit margin
22.53%
Revenue growth QoQ
6.60%
Beta
1.36
$554.99 1.82%
Price as of 2026-08-28 · NASDAQ

Performance by timeframe

Rolling returns
1 Month -0.68%
6 Months -12.83%
1 Year -14.23%
5 Years -4.18% p.a.-19.21%
10 Years +17.30% p.a.+392.54%
Since inception +19.95% p.a.+9,314.59%
Calendar year returns
YTD -17.97%
2025 +63.63%
2024 -25.51%
2023 +36.06%
2022 -38.04%
2021 +31.73%

Key stats

Market cap
34.63B
P/E
40.82
Beta
1.36
52-week range
398.50 - 583.39
50-day MA
423.43
200-day MA
473.52
Section 1

Business overview

Company profile data from fundamentals.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Sector Healthcare
Industry Diagnostics & Research
Country United States
Exchange NASDAQ
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 59.42%
ROA 22.79%
Profit margin 22.53%
Operating margin 37.46%
PEG ratio 4.41
Revenue/share TTM 46.45
Revenue TTM 3.84B
EBITDA 1.30B
Gross profit TTM 2.33B
Beta 1.36

Valuation

Trailing P/E 40.82
Forward P/E 37.04
P/B 21.19
P/S 9.01
EV/EBITDA 27.93
EV/Revenue 9.10

ESG Scores

Total ESG 29.8
Environment 9.9
Social 14.4
Governance 17.9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 10.73
Quarterly earnings growth 10.70%
Revenue TTM 3.84B
Reported quarters 118
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0.00%
Split factor 2:1
Last split date 2015-06-16
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $478.62
Analyst rating 3.6429

Ownership & short interest

Shares outstanding 81.88M
Shares float 80.97M
Institutional ownership 95.14%
Insider ownership 94.30%
Short ratio 2.57
Short % of float 2.35%

Details

Instrument metadata and source update timestamps.

Symbol IDXX
Name IDEXX Laboratories Inc
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US45168D1046
Country USA
Code + exchange IDXX.NASDAQ
Fundamentals updated 2025-01-16

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.